Eversept Partners »

Compass Pathways shares owned by Eversept Partners

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 678k 5.53

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Compass Pathways

Deep Track Capital
Rtw Investments
Marshall Wace
Tang Capital Management
Caption Management
BIT Capital GmbH
Susquehanna International
ARK Investment Management
Millennium Management
GMT Capital Corp
Two Sigma Investments
DAFNA Capital Management
Baker Bros. Advisors
Eagle Health Investments
UBS Group

View all funds holding Compass Pathways